Cohort Study: Association of Treatment With 5α-Reductase Inhibitors and Prostate Cancer Mortality
27 Oct, 2019 | 19:27h | UTCCommentary: Association between 5α-reductase inhibitors, prostate cancer mortality replicated – Medicine Matters (free)
Related Study: Use of 5α-reductase Inhibitors is Associated with Delayed Prostate Cancer Diagnosis and Increased Mortality in Men Undergoing PSA Screening (link to abstract and commentary)